Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pharm ; 534(1-2): 42-49, 2017 Dec 20.
Article in English | MEDLINE | ID: mdl-28986320

ABSTRACT

Systemic delivery of therapeutic proteins to the central nervous system (CNS) is challenging because of the blood-brain barrier restrictions. Direct intrathecal delivery is possible but does not produce stable concentrations. We are proposing an alternative approach for localized delivery into the CNS based on the Transduced Autologous Restorative Gene Therapy (TARGT) system. This system was previously developed using a gene therapy approach with dermal tissue implants. Lewis rat dermal tissue was transduced to secrete human EPO (hEPO). TARGT viability and function were retained following cryopreservation. Upon implantation into the rat cisterna magna, a mild inflammatory response was observed at the TARGT-brain interface throughout 21-day implantation. hEPO expression was verified immunohistochemically and by secreted levels in cerebrospinal fluid (CSF), serum, and in vitro post explant. Detectable CSF hEPO levels were maintained during the study. Serum hEPO levels were similar to rat and human basal serum levels. In vitro, the highest hEPO concentration was observed on day 1 post-explant culture and then remained constant for over 21days. Prolonged incubation within the cisterna magna had no negative impact on TARGT hEPO secretion. These promising results suggest that TARGTs could be utilized for targeted delivery of therapeutic proteins to the CNS.


Subject(s)
Delayed-Action Preparations/administration & dosage , Proteins/administration & dosage , Animals , Blood-Brain Barrier/metabolism , Central Nervous System/drug effects , Cerebrospinal Fluid/metabolism , Cryopreservation/methods , Erythropoietin/administration & dosage , Genetic Therapy/methods , Genetic Vectors/metabolism , Humans , Injections, Spinal/methods , Rats , Rats, Inbred Lew , Serum/metabolism
3.
Appl Microbiol Biotechnol ; 58(1): 39-45, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11831474

ABSTRACT

s-Triazine ring compounds are common industrial chemicals: pesticides, resin intermediates, dyes, and explosives. The fate of these compounds in the environment is directly correlated with the ability of microbes to metabolize them. Microbes metabolize melamine and the triazine herbicides such as atrazine via enzyme-catalyzed hydrolysis reactions. Hydrolytic removal of substituents on the s-triazine ring is catalyzed by enzymes from the amidohydrolase superfamily and yields cyanuric acid as an intermediate. Cyanuric acid is hydrolytically processed to yield 3 mol each of ammonia and carbon dioxide. In those cases studied, the genes underlying the hydrolytic reactions are localized to large catabolic plasmids. One such plasmid, pADP-1 from Pseudomonas sp. ADP, has been completely sequenced and contains the genes for atrazine catabolism. Insertion sequence elements play a role in constructing different atrazine catabolic plasmids in different bacteria. Atrazine chlorohydrolase has been purified to homogeneity from two sources. Recombinant Escherichia coli strains expressing atrazine chlorohydrolase have been constructed and chemically cross-linked to generate catalytic particles used for atrazine remediation in soil. The method was used for cleaning up a spill of 1,000 pounds of atrazine to attain a level of herbicide acceptable to regulatory agencies.


Subject(s)
Atrazine/metabolism , Herbicides/metabolism , Hydrolases/metabolism , Pseudomonas/enzymology , Triazines/metabolism , Atrazine/chemistry , Biodegradation, Environmental , Escherichia coli/enzymology , Escherichia coli/genetics , Herbicides/chemistry , Hydrolases/genetics , Pseudomonas/genetics , Soil Pollutants/metabolism , Triazines/chemistry
4.
Can J Microbiol ; 46(5): 425-32, 2000 May.
Article in English | MEDLINE | ID: mdl-10872078

ABSTRACT

The potential of soil microorganisms to mineralize atrazine was studied in soil samples collected from fields with various histories of atrazine application. In contrast to many previous studies, which showed no atrazine mineralization activity, all the tested soils mineralized atrazine regardless of their atrazine application history. However, the delay before mineralization and the variation in the subsequent mineralization rate were in agreement with the initial copy number of the atrazine dechlorinaze gene, and the proliferation rate of the degraders. Soils from corn fields, which had up to 100 copies of the atzA gene per gram of soil, had a lag period of 4-5 days before atrazine mineralization started, and final mineralization percentages ranged from 40% to 54%. However, soils from fields that were never amended with atrazine had much longer lag periods (more than 17 days), which decreased after enrichment of the degrader population with high concentrations of atrazine for 15 days. Generally the mineralization rate and the atzA gene copy number increased after the enrichment period. The atrazine mineralization potential was measured by PCR of genes from the atrazine mineralization pathway. Magnetic capture hybridization was the most efficient of the two tested methods for purifying target DNA of PCR inhibitors, without reducing the copy number of the required fragment. Nested PCR proved to be the most effective method for predicting the exact potential of the soil to mineralize the pollutant even without enrichment of a small population with the target genes. This method can complement microcosm studies and eliminate futile efforts when the potential to mineralize the pollutant does not exist in the soil.


Subject(s)
Atrazine/metabolism , Bacteria/metabolism , Herbicides/metabolism , Polymerase Chain Reaction/methods , Soil Microbiology , Bacteria/genetics , Hydrolases/genetics , Hydrolases/metabolism , Magnetics , Microspheres , Nucleic Acid Hybridization/methods , Soil Pollutants/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...